相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute Hypertensive Response in Patients With Acute Intracerebral Hemorrhage A Narrative Review
Maximiliano A. Hawkes et al.
NEUROLOGY (2021)
Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities
Qian Bai et al.
BRAIN (2020)
Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
Christine Tschoe et al.
JOURNAL OF STROKE (2020)
Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation
Mengzhou Xue et al.
LANCET NEUROLOGY (2020)
Resuming Anticoagulation After Cerebral Intraparenchymal Hemorrhage Reply
Bradley A. Gross et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk
Alexey Polonikov et al.
HYPERTENSION RESEARCH (2019)
Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage
Jieru Wan et al.
STROKE AND VASCULAR NEUROLOGY (2019)
Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
Chun-Hu Wu et al.
JOURNAL OF NEUROINFLAMMATION (2017)
CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population
Xingyang Yi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Association of CYP2J2 gene polymorphisms with ischemic stroke and stroke subtypes in Chinese population
Si-Yang Wang et al.
MEDICINE (2017)
CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population
Xingyang Yi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Cerebral Small Vessel Disease is Associated with Genetic Variations in CYP2J
Ming Yao et al.
CURRENT NEUROVASCULAR RESEARCH (2017)
Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium
Jia Jia et al.
EXPERIMENTAL NEUROLOGY (2016)
Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients
Reni Tzveova et al.
BIOCHEMICAL GENETICS (2015)
Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage
Mark K. Donnelly et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance
Meijuan Xu et al.
DRUG METABOLISM REVIEWS (2013)
Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice
Ketul R. Chaudhary et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Roles of the epoxygenase CYP2J2 in the endothelium
Ara Askari et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Activity, Inhibition, and Induction of Cytochrome P450 2J2 in Adult Human Primary Cardiomyocytes
Eric A. Evangelista et al.
DRUG METABOLISM AND DISPOSITION (2013)
Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?
Cristiano Fava et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2012)
Are Myocardial Infarction-Associated Single-Nucleotide Polymorphisms Associated With Ischemic Stroke?
Yu-Ching Cheng et al.
STROKE (2012)
Tissue Distribution and Gender-Divergent Expression of 78 Cytochrome P450 mRNAs in Mice
Helen J. Renaud et al.
TOXICOLOGICAL SCIENCES (2011)
Haplotype analysis of the CYP2J2 gene associated with myocardial infarction in a Chinese Han population
Zeng Jie et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Causal Relationship of Susceptibility Genes to Ischemic Stroke: Comparison to Ischemic Heart Disease and Biochemical Determinants
Paul Bentley et al.
PLOS ONE (2010)
Genetic variance in CYP2C8 and increased risk of myocardial infarction
Eline M. Rodenburg et al.
PHARMACOGENETICS AND GENOMICS (2010)
Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort
Elisabeth Haschke-Becher et al.
PHARMACOGENOMICS (2010)
Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function
Fabien Dutheil et al.
DRUG METABOLISM AND DISPOSITION (2009)
Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies
Elizabeth B. Daily et al.
PHARMACOGENOMICS (2009)
Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension
Sheng-Nan Wu et al.
ANNALS OF HUMAN GENETICS (2007)
CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk:: the Atherosclerosis Risk in Communities (ARIC) study
Craig R. Lee et al.
PHARMACOGENETICS AND GENOMICS (2007)
Fibrinolytic gene polymorphism and ischemic stroke
K Jood et al.
STROKE (2005)
Cytochrome P450 in neurological disease
M Liu et al.
CURRENT DRUG METABOLISM (2004)
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2
M Spiecker et al.
CIRCULATION (2004)
Cloning of CYP2J2 gene and identification of functional polymorphisms
LM King et al.
MOLECULAR PHARMACOLOGY (2002)
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
D Dai et al.
PHARMACOGENETICS (2001)
Identifying endothelium-derived hyperpolarizing factor: Recent approaches to assay the role of epoxyeicosatrienoic acids
M Medhora et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
分享论文
